Valuing end-of-life care in the United States: the case of new cancer drugs

Publisher: Cambridge University Press

E-ISSN: 1744-134x|7|4|411-430

ISSN: 1744-1331

Source: Health Economics, Policy and Law, Vol.7, Iss.4, 2012-10, pp. : 411-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract